parkinson glutathione therapy for Gut microbiota and Parkinson's disease: exploring pathogenesis and potential therapeutic strategies from a gut-brain axis perspective The Search for Disease Modification – Central nervous system uptake of

So far, internationally we have no test that can replace the Schillings Test II, examining the uptake of B12 when it is supplied together with intrinsic factor

[DOI] [PubMed] [Google Scholar] 84.Rasmussen R.A., Sisson S.B., Baldwin J.D., Hord N., Eliot K., Anderson L., Gowin M.J., Scott B.D., Wortham D

26 and the references therein), they have limitations associated with well-known multiple adverse reactions, genotoxicity, and special requirements for storage, handling, and administration, posing challenges with respect to the standard operating procedure (SOP) for MDA campaigns requiring single or double dose activity, oral administration, minimal toxicity, and stability in tropical settings 27

A., Lee, S